Allergan Aesthetics announced the U.S. FDA approval of Skinvive by Juvederm to improve skin smoothness of the cheeks in adults over the age of 21. Skinvive by Juvederm is the first and only hyaluronic acid (HA) intradermal microdroplet injection for skin smoothness available in the U.S. with results lasting through six months with optimal treatment.
Skinvive by Juvederm is a smooth, injectable HA gel that contains a small amount of local anesthetic (lidocaine). Unlike other facial injectables that enhance and augment the treatment area, Skinvive by Juvederm improves skin quality in the cheeks by smoothing the skin and increasing hydration. It is a specialized, smooth, hydrating gel that flows easily into the skin and is approved for all Fitzpatrick Skin Types I-VI, lightest to darkest, addressing an important unmet need in the skin quality category. The product was designed with global skin health experts to improve smoothness of the cheeks leading to a lasting glow. Treatment is minimally invasive, offers little to no downtime, and provides results over the course of six months without requiring a recurring series of treatments. "Skinvive by Juvederm is a category-creating HA product that leaves skin looking healthier, more glowing, and more hydrated," says Carrie Strom, president, Global Allergan Aesthetics and senior vice president, AbbVie. "This unique product is a result of our vast experience in HA science and complements our current collection of HA products, with the Juvederm Collection of Fillers and SkinMedica topicals."
Patients who receive aesthetic treatment from the Allergan Aesthetics portfolio of products can also enroll in Allē, Allergan Aesthetics loyalty rewards program to unlock access to curated content, exclusive offers, and personalized rewards that can be used for savings on the Allergan Aesthetics portfolio of products and redeemed at a participating provider's office, subject to applicable program terms and conditions. Allē is the first and only loyalty program in the aesthetics market to also offer consumers the ability to earn points on over 40 non-Allergan Aesthetics treatments and brands.
As sometimes happens with novel products, the FDA has required that Allergan Aesthetics provide a training program for all interested providers. Successful completion of this training is necessary prior to purchase of and administration of Skinvive by Juvederm.